Holland Capital Invests in Curess

Amsterdam, June 20th, 2024 – Holland Capital participates in Curess, a leading organization in youth care focused on systemic family support. Through the collaboration with Holland Capital, further growth and development can be achieved.

Systemic Family Support

Curess offers specialized ambulatory youth care (such as intensive systemic guidance, ambulatory emergency help, perspective research, and co-parenting investigations) and focuses on strengthening families through practical and directly applicable assistance. Curess operates without waiting lists and can scale its operations up and down quickly, to deliver the desired care swiftly and with high quality. The organization achieves this by applying self-developed software that supports core processes (such as planning) and thus reduces administrative pressure.

Strategic Parntership

With this strategic partnership, Curess has found a partner to achieve its ambitious strategic goals.

Eddy de Bruin, CEO of Curess, states: “With the support of Holland Capital, we can realize our ambitions and help even more young people and families. With their expertise and resources, we are better equipped to significantly increase our impact in youth care. We are committed to providing the necessary support to families to learn to live together better, without waiting lists, through our dedicated professionals.”

Margot Engels, Healthcare Partner at Holland Capital, adds: “We are proud to add Curess to our portfolio. Curess provides crucial support to families in an innovative way, and we look forward to working together on their growth ambitions and further professionalization of their services. Our shared vision is to provide the best possible care and support.”

About Curess

With over 200 registered professionals, Curess offers specialized ambulatory youth care to young people and families to ensure they can live together better. By utilizing personal and innovative methods, Curess strives for a safe and supportive environment for children and their families. Curess is active in the regions of Twente, Midden-IJssel, Oost-Veluwe, Noord-Veluwe, Achterhoek, and Zuid-Drenthe

About Holland Capital

Holland Capital has been responsibly and successfully investing in promising Dutch and German SMEs with growth ambitions for over 40 years. The team understands entrepreneurship and strives for an open, sustainable, and professional relationship with the management teams of the companies they invest in, with the common goal of realizing growth. Holland Capital has offices in Amsterdam and Düsseldorf. With specialized sector teams, it focuses on the Healthcare, Technology, and Agrifood-Tech sectors. They understand the dynamics and opportunities, and have an extensive network in these sectors.

 The participation in Curess fits within Holland Capital’s strategy to invest in companies that contribute to societal challenges and create value for society. With this investment, Holland Capital takes an important step in further strengthening its portfolio within the healthcare sector.

Holland Venture start nieuw private equity fonds

Amsterdam, 1 juli 2009 - Holland Venture heeft een nieuw private equity fonds van 70 miljoen euro opgezet dat zich richt op groei- en buy-out investeringen in de Benelux. De doelgroep van het fonds bestaat uit bestaande ondernemingen met een ondernemingswaarde tussen...

Verkoop Orthos Europe BV aan Atrium Innovations Inc.

Amsterdam, 22 september 2008 - Holland Venture heeft vandaag haar meerderheidsbelang in Orthos Europe BV verkocht. Orthos Europe BV houdt 100% van de aandelen van AOV Orthomoleculaire Voedingssupplementen BV, een onderneming die hooggedoseerde voedingssupplementen...

Holland Venture verkoopt haar aandelen in INS Group S.A.

Amsterdam, 12 september 2007 - Holland Venture is verheugd om u te kunnen melden dat zij haar aandelen in INS Group, een in België gevestigd netwerk and systemen integrator, aan BT verkocht heeft. Met BT is overeengekomen dat zij 100% van de aandelen in INS Group...

Vacature Investment Analyst Healthcare BO

Investment Manager buy-out HealthcareInvestment Manager buy-out Healthcare Sector: Private Equity en Venture Capital Locatie: Amsterdam Opleidingsniveau: WO Over onze organisatie Holland Capital is een succesvolle participatiemaatschappij welke zich richt op...

CytoSMART haalt 5,2 miljoen euro op voor productinnovatie en groei

CytoSMART haalt 5,2 miljoen euro op voor productinnovatie en groei Eindhoven, 25 maart 2019 - CytoSMART, de Eindhovense ontwikkelaar en fabrikant van digitale microscopen voor het monitoren van celkweekprocessen, ontvangt een groeifinanciering van 5,2 miljoen euro....

Amsterdam
Krijn Taconiskade 426
1087 HW Amsterdam
+31 (0) 20 3119411

 

Düsseldorf
Königsallee 42
40212 Düsseldorf
+49 (0) 211 96290120

Contact
info@hollandcapital.nl